Fagron (FRA:4A5) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4A5 Fagron SA FRA:4A5
92 GF Score
Price €23.85
GF Value €23.75
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Fagron Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:4A5
92GF Score
Fagron SA FRA:4A5
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fagron (FRA:4A5) Overvalued in 2026?

Based on GuruFocus' analysis, Fagron stock appears to be overvalued. The current stock price of €23.85 is trading 0.4% above its estimated GF Value™ of €23.75. GuruFocus considers Fagron to be Fairly Valued.

Key valuation signals for FRA:4A5:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €23.75 vs. price of €23.85 (0.4% above fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the FRA:4A5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fagron Business Description

Other Exchanges FAGRb:UK0HNZ:UKFAGR:Belgium
Address Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
92GF Score

Get the complete analysis for FRA:4A5

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.85
Price
€23.75
GF Value